• Tacrolimus (FK506): Reading Calcineurin Assays

  2026-08-30

  Tacrolimus and FK506 are often treated as simple calcineurin inhibitors, but their experimental meaning depends on immunophilin context, assay readouts, and exposure design. This guide connects molecular mechanism with genetically informed controls and reproducible model selection.

• Physiological and Pathological Aβ in Human Synapses

  2026-08-29

  McGeachan and colleagues use live human brain slice cultures to distinguish how physiological Aβ fluctuations differ from Alzheimer’s disease-associated Aβ in their effects on synapses. The study links donor characteristics and regional biomarker release to divergent structural, uptake, and transcriptional responses, providing a human-tissue framework for studying early synaptic pathology.

• Pazopanib Hydrochloride Cancer Assay Workflows

  2026-08-28

  Build more informative angiogenesis and tumor-response assays with Pazopanib Hydrochloride (GW786034), a multi-target kinase inhibitor suited to both signaling and phenotype studies. This workflow separates growth inhibition from cell killing so apparent potency is not mistaken for cytotoxicity.

• Y-27632: Reading Force, Shape, and Cell Fate

  2026-08-28

  Y-27632 is a selective ROCK inhibitor for dissecting how actomyosin tension, focal adhesions, and cell geometry influence experimental outcomes. This article translates MSC mechanobiology findings into a force-aware assay strategy that separates cytoskeletal dynamics modulation from downstream cell-fate interpretation.

• GSK2606414: A Causal PERK Probe for NAFLD

  2026-08-28

  GSK2606414 is a selective PERK inhibitor for testing whether ER-stress signaling drives metabolic liver injury. This article develops a causal assay framework around TMAO-induced NAFLD, connecting pathway engagement, phenotype rescue, selectivity, and experimental controls.

• Z-VDVAD-FMK: Reliable Caspase-2 Assays

  2026-08-27

  Learn how Z-VDVAD-FMK, SKU A1922, can improve interpretation of apoptosis, viability, and caspase activity experiments through pathway-focused inhibition and disciplined controls. This scenario-based guide covers assay design, DMSO preparation, storage, data interpretation, cross-domain limitations, and practical vendor selection.

• GOB-38 in Elizabethkingia anophelis: Biochemical Insights

  2026-08-26

  The reference study characterizes GOB-38, a B3-Q metallo-β-lactamase from a clinical Elizabethkingia anophelis isolate, using recombinant expression, purified-enzyme analysis, genomic investigation, and bacterial co-culture. Its broad hydrolytic profile and distinctive active-site residues help explain resistance to multiple β-lactam classes, while the co-isolation data raise important questions about resistance dissemination during polymicrobial infection.

• Imipenem as a Translational Resistance Lens

  2026-08-26

  Imipenem is more than a broad-spectrum antibacterial benchmark. Its PBP-directed mechanism, immune-response observations, and performance in resistance-focused workflows create a practical framework for linking bacterial phenotype, carbapenemase genetics, and sepsis biology. This thought-leadership guide shows translational researchers how to use Imipenem strategically while avoiding overinterpretation of in vitro, genomic, and animal-model findings.

• Fluorescence-Trackable Coatings for Magnesium Implants

  2026-08-26

  The reference study combines chitosan corrosion control with NaYF4:Yb,Er upconversion nanoparticles to create an AZ31 magnesium interface that can be optically monitored during degradation. Its coated alloys reduced corrosion-related changes, supported osteogenic responses in MC3T3-E1 cells, and improved bone-regeneration indicators in a rat calvarial defect model.

• Perospirone Inhibits Kv1.5 in Coronary Smooth Muscle

  2026-08-25

  A 2025 Journal of Applied Toxicology study identifies a previously unrecognized vascular ion-channel action of Perospirone in freshly isolated rabbit coronary arterial smooth muscle cells. The drug inhibited Kv currents through a concentration-dependent, use-independent process with pharmacological evidence implicating Kv1.5, extending antipsychotic drug mechanism research into cardiovascular safety and vascular physiology.

• Reelin–SFK Signaling in Ketamine Response

  2026-08-24

  The 2021 PNAS study shows that Reelin–Apoer2–Src family kinase signaling is a permissive requirement for ketamine-induced hippocampal plasticity and antidepressant-like behavioral effects. By combining genetic deletion, pharmacological perturbation, electrophysiology, and biochemical analysis, the work provides a mechanistic framework for studying variable ketamine responsiveness without reducing the phenomenon to NMDA receptor blockade alone.

• PPACK Dihydrochloride in Thrombin Assays

  2026-08-24

  PPACK Dihydrochloride provides a high-affinity, irreversible thrombin checkpoint for separating protease-driven coagulation from platelet receptor signaling. This guide translates that property into practical assay workflows, controls, optimization steps, and interpretation strategies informed by selective P2X1 research.

• Coumestrol–TRIM3–PMAIP1 Ferroptosis in RA

  2026-08-23

  A 2026 study links Coumestrol treatment to ferroptosis in rheumatoid arthritis fibroblast-like synoviocytes through stabilization of mitochondrial PMAIP1. The work identifies suppression of TRIM3-mediated ubiquitin–proteasome down-regulation as a mechanistic explanation for reduced synoviocyte proliferation and inflammatory cytokine production.

• HCAR3 Agonist Selectivity Revealed by Cryo-EM

  2026-08-22

  Ye et al. used cryo-EM and cAMP signaling assays to define how HCAR3 recognizes several agonists and how its binding pocket differs from HCAR2. The structures identify ligand-contact features that may guide HCAR3-focused studies of lipid metabolism while helping researchers interpret receptor selectivity and assay design.

• ZIF8 Nanotheranostics for Ultrasound-Guided TNBC Therapy

  2026-08-21

  Li et al. developed FA-PEG@ZIF8@CIP, a folate-targeted ZIF8 nanoplatform that combines ultrasound imaging, pH-responsive ciprofloxacin release, sonodynamic therapy, chemotherapy, and immune activation for triple-negative breast cancer. The study links ultrasound-triggered reactive oxygen species production with immunogenic cell death and increased CD8+ T-cell infiltration, while also identifying important translational questions about dosing, ultrasound parameters, safety, and tumor heterogeneity.

8670 records 1/578 page Next 12345 下5页 Last page